Updating results

Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (TA293)

Evidence-based recommendations on eltrombopag (Revolade) for treating chronic immune (idiopathic) thrombocytopenic purpura (chronic ITP)

Technology appraisal guidance Published July 2013 Last updated October 2018

Myeloma: diagnosis and management (NG35)

This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications.

NICE guideline Published February 2016 Last updated October 2018

Lyme disease (NG95)

This guideline covers diagnosing and managing Lyme disease. It aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. It does not cover preventing Lyme disease.

NICE guideline Published April 2018 Last updated October 2018

Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma (TA544)

Evidence-based recommendations on dabrafenib (Tafinlar) with trametinib (Mekinist) for resected stage III, BRAF V600 mutation-positive melanoma in adults

Technology appraisal guidance Published October 2018

Making a difference to the lives of those we serve

Natasha Sloman, head of Hospital Inspection at the Care Quality Commission (CQC), discusses how working with NICE has been fundamental in making her work a success

News Published October 2018 Last updated October 2018

Mental health in a changing world

Paige Ataou shares her experience of mental health in the changing world and talks about environment and relationships

News Published October 2018 Last updated October 2018

Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)

Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people

Highly specialised technologies guidance Published October 2018

NICE says non-surgical options should be offered first for stress urinary incontinence or pelvic organ prolapse

Women should be offered the treatment option of their choice, in discussion with their clinician

News Published October 2018 Last updated October 2018

Being a NICE Scholar will broaden your knowledge of health and social care

Katie Currie, public health principal, outlines how the NICE Scholar programme shaped her career development

News Published October 2018 Last updated October 2018

New decision making guideline will help maximise personal autonomy

Nageena Khalique QC, barrister and chair of the committee for the NICE guideline on Decision making and mental capacity, discusses how the new guideline applies to a range of situations

News Published October 2018 Last updated October 2018

Patients to be offered choice over setting and type of dialysis treatment, NICE says

Dialysis choice allows patients to live the life they want to

News Published October 2018 Last updated October 2018

Decision-making and mental capacity (NG108)

This guideline covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so. It also helps practitioners to keep people who lack capacity at the centre of the decision-making process.

NICE guideline Published October 2018

Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA543)

Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis after inadequate response to DMARDs in adults

Technology appraisal guidance Published October 2018

Cabozantinib for untreated advanced renal cell carcinoma (TA542)

Evidence-based recommendations on cabozantinib (Cabometyx) for untreated advanced renal cell carcinoma in adults

Technology appraisal guidance Published October 2018

Renal replacement therapy and conservative management (NG107)

This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating care.

NICE guideline Published October 2018

iFuse for treating chronic sacroiliac joint pain (MTG39)

Evidence-based recommendations on iFuse titanium implant joint fusion system for treating chronic sacroiliac (SI) joint pain (lower back pain)

Medical technologies guidance Published October 2018

E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)

Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta

Medical technologies guidance Published December 2013 Last updated October 2018

Has NICE guidance helped your organisation up its game? Enter the 2019 Shared Learning Awards

The 2019 Shared Learning Awards are now open for entries.

News Published September 2018 Last updated September 2018

Double check patients with 'penicillin allergy' to avoid increased MRSA risk

People who incorrectly believe they are allergic to penicillin are unnecessarily put at an increased risk of developing MRSA or C difficile, NICE warns today.

News Published September 2018 Last updated September 2018

NICE responds to feedback on eating disorders quality initiatives

A new NICE quality standard (QS) on eating disorders focuses on promoting early access and coordinating care between services.

News Published September 2018 Last updated September 2018

Consider electric or hybrid NHS and local authorities urged to reduce vehicle air pollution

Driver training and car sharing should also be considered in bid to reduce emissions

News Published September 2018 Last updated September 2018

NICE encourages further discussions on Kymriah for adult lymphoma

CAR-T is too expensive to recommend as a treatment for adults with lymphoma, NICE says in draft guidance today (19 September).

News Published September 2018 Last updated September 2018

Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG629)

Evidence-based recommendations on transurethral water jet ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published September 2018

Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer (IPG628)

Evidence-based recommendations on intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer

Interventional procedures guidance Published September 2018

Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia (TA541)

Evidence-based recommendations on inotuzumab ozogamicin (Besponsa) for relapsed/refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL)

Technology appraisal guidance Published September 2018

Being a NICE Fellow has been a fantastic experience

Dr Julia Terry discussed how her experience as a NICE Fellow enhanced her academic career

News Published September 2018 Last updated September 2018

Patients with high-risk skin cancer have new treatment option

Hundreds of patients with a type of advanced skin cancer are set to benefit from a new treatment, dabrafenib plus trametinib.

News Published September 2018 Last updated September 2018

Chronic heart failure in adults: diagnosis and management (NG106)

This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.

NICE guideline Published September 2018

Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)

Evidence-based recommendations on Neuropad for detecting preclinical diabetic peripheral neuropathy (nerve damage) by detecting inadequate sweat production

Medical technologies guidance Published September 2018

Preventing suicide in community and custodial settings (NG105)

This guideline covers ways to reduce suicide and help people bereaved or affected by suicides. It aims to:

NICE guideline Published September 2018

Let's talk about risk and lifestyle change

Dr Finnikin explains how he approaches patients about cardiovascular risk and changes to lifestyle

News Published September 2018 Last updated September 2018

Pancreatitis (NG104)

This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.

NICE guideline Published September 2018

Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma (TA540)

Evidence-based recommendations on pembrolizumab (Keytruda) for treating relapsed or refractory classical Hodgkin lymphoma (cHL) in adults

Technology appraisal guidance Published September 2018

New “life changing” procedure can be offered to adults with severe asthma on NHS

Procedure could be an option for adults with severe asthma whose symptoms cannot be adequately controlled with drugs

News Published August 2018 Last updated August 2018

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours (TA539)

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults

Technology appraisal guidance Published August 2018

Superior rectal artery embolisation for haemorrhoids (IPG627)

Evidence-based recommendations on superior rectal artery embolisation for haemorrhoids in adults

Interventional procedures guidance Published August 2018

Leadless cardiac pacemaker implantation for bradyarrhythmias (IPG626)

Evidence-based recommendations on leadless cardiac pacemaker implantation for bradyarrhythmias (an inserted device to help the heart beat at a normal rate)

Interventional procedures guidance Published August 2018

Feedback encouraged to allow use of life extending treatment on NHS for those with blood cancer

CAR-T considered to be an exciting innovation which can cure some patients but very expensive

News Published August 2018 Last updated August 2018

Antibiotics should not be issued as first line of treatment for a cough, says NICE and PHE

People should take honey or cough medicines instead but speak to their GP if it persists for longer than three weeks

News Published August 2018 Last updated August 2018

Sutureless aortic valve replacement for aortic stenosis (IPG624)

Evidence-based recommendations on sutureless aortic valve replacement for aortic stenosis in adults

Interventional procedures guidance Published August 2018

Flu vaccination: increasing uptake (NG103)

This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be encouraged to have the vaccination.

NICE guideline Published August 2018

Dinutuximab beta for treating neuroblastoma (TA538)

Evidence-based recommendations on dinutuximab beta (Qarziba) for high-risk neuroblastoma in people aged 12 months and over

Technology appraisal guidance Published August 2018

Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG625)

Evidence-based recommendations on transurethral water vapour ablation for lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH)

Interventional procedures guidance Published August 2018

NICE would welcome further discussions about access to spinal muscular atrophy drug nusinersen

NICE hopes for further talks over nusinersen for treating a rare genetic disorder; spinal muscular atrophy (SMA).

News Published August 2018 Last updated August 2018

Allied Health Professionals into action

Naomi introduces the NICE into Action webinar series and tells us why this is important for the allied health professions.

News Published August 2018 Last updated August 2018

Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA537)

Evidence-based recommendations on ixekizumab (Taltz) for treating active psoriatic arthritis after inadequate response to DMARDs in adults

Technology appraisal guidance Published August 2018

Alectinib for untreated ALK-positive advanced non-small-cell lung cancer (TA536)

Evidence-based recommendations on alectinib (Alecensa) for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults

Technology appraisal guidance Published August 2018

Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (TA535)

Evidence-based recommendations on lenvatinib (Lenvima) and sorafenib (Nexavar) for differentiated thyroid cancer in adults who have had radioactive iodine

Technology appraisal guidance Published August 2018

Community pharmacies: promoting health and wellbeing (NG102)

This guideline covers how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with a long-term condition. It aims to encourage more people to use community pharmacies by integrating them within existing health and care pathways and ensuring they offer standard services and a consistent approach. It requires a collaborative approach from individual pharmacies and their representatives, local authorities and other commissioners.

NICE guideline Published August 2018

Dupilumab for treating moderate to severe atopic dermatitis (TA534)

Evidence-based recommendations on dupilumab (Dupixent) for treating moderate to severe atopic dermatitis in adults

Technology appraisal guidance Published August 2018